Teva Pharmaceutical Indus Market Sentiment

Teva Pharmaceutical Industries Ltd

TEVANYSE

Trade with Public

$39.95

0.541.37%

마지막 업데이트: Oct 26, 4:00 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 화 11월 3rd에 개장 전 7일 후 후에 발표됩니다.

컨퍼런스 콜: 7일 후 8:00 오전에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

Teva Pharmaceutical Indus Market Sentiment - Benzinga

Teva Pharmaceutical Indus Market Sentiment

Market sentiment signals for Teva Pharmaceutical Indus (TEVA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.6% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

15 analysts

Options Flow (P/C)

—

Avg Consensus PT

$40

+0.3%

Highest Price Target

$55

+37.7%

TD Cowen

Lowest Price Target

$11

-72.5%

Goldman Sachs

Short Interest

2.6%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 15, 2026	Barclays	Glen Santangelo—	+17.6%	$42 → $47	Maintained	Overweight
Oct 12, 2026	JP Morgan	Chris Schott—	+25.2%	$40 → $50	Maintained	Overweight
Oct 1, 2026	TD Cowen	Joseph Thome—	+37.7%	$55	Initiate	Buy
Sep 23, 2026	Oppenheimer	Les Sulewski—	+25.2%	$50	Initiate	Outperform
Sep 9, 2026	Leerink Partners	Daniel Clark—	+12.6%	$45	Initiate	Outperform
Sep 4, 2026	UBS	Ashwani Verma—	+20.2%	$42 → $48	Maintained	Buy
Aug 12, 2026	Barclays	Glen Santangelo—	+5.1%	$40 → $42	Maintained	Overweight
Jul 28, 2026	Piper Sandler	David Amsellem—	+10.1%	$42 → $44	Maintained	Overweight
May 6, 2026	Barclays	Glen Santangelo—	+0.1%	$38 → $40	Maintained	Overweight
Apr 30, 2026	Truist Securities	Les Sulewski—	+12.6%	$42 → $45	Maintained	Buy
Apr 30, 2026	Piper Sandler	David Amsellem—	+5.1%	$41 → $42	Maintained	Overweight
Apr 30, 2026	UBS	Ashwani Verma—	+5.1%	$36 → $42	Maintained	Buy
Apr 30, 2026	JP Morgan	Chris Schott—	+0.1%	$35 → $40	Maintained	Overweight
Apr 9, 2026	B of A Securities	Jason Gerberry—	+5.1%	$38 → $42	Maintained	Buy
Mar 4, 2026	Piper Sandler	David Amsellem—	+2.6%	$40 → $41	Maintained	Overweight
Feb 18, 2026	Truist Securities	Les Sulewski—	+5.1%	$38 → $42	Maintained	Buy
Feb 9, 2026	Goldman Sachs	Matt Dellatorre—	+12.6%	$36 → $45	Maintained	Buy
Jan 30, 2026	Barclays	Glen Santangelo—	-4.9%	$35 → $38	Maintained	Overweight
Jan 29, 2026	Truist Securities	Les Sulewski—	-4.9%	$36 → $38	Maintained	Buy
Jan 29, 2026	Scotiabank	Louise Chen—	+0.1%	$35 → $40	Maintained	Sector Outperform
Jan 6, 2026	Jefferies	Glen Santangelo—	+0.1%	$29 → $40	Maintained	Buy
Dec 22, 2025	Piper Sandler	David Amsellem—	+0.1%	$30 → $40	Maintained	Overweight
Dec 19, 2025	Goldman Sachs	Matt Dellatorre—	-12.4%	$31 → $35	Maintained	Buy
Dec 16, 2025	JP Morgan	Chris Schott—	-12.4%	$28 → $35	Maintained	Overweight
Dec 9, 2025	Barclays	Glen Santangelo—	-12.4%	$35	Initiate	Overweight